About the Session
Neuromodulation Special Interest Group Symposium: PM Sessions
Learning Objectives:
- Learn the objective of screening trials.
- Explore the available information on the diagnostic value of screening trials.
- Learn the patient benefit of screening trials as well as the potential economic impact.
Schedule
13:00 – Symposia Begins and Opening Remarks
13:30-14:15 – A Review of the Guidelines and Clinical Conduct of Trial in Neurmodulation Therapies with Dr John Markman Rochester (USA)
14:15-14:30 – Q&A
14:30-15:15 – A Systematic Review of the Evidence on Conduct of Trials in Spinal Cord Stimulation with Dr Harsha Shantana (Canada)
15:15-15:30 – Q&A
15:30-16:15 – Patient Benefit and Economic Impact of conduct of screening trials in Spinal Stimulation and Intrathecal Drug Delivery with Prof Sam Eldabe Middlesbrough UK
16:15-16:30 – Q&A
16:30 – Closing Remarks
Categories Sig Symposia